116 related articles for article (PubMed ID: 24258994)
1. Epigenetic markers of prognosis in melanoma.
Sigalotti L; Fratta E; Parisi G; Coral S; Maio M
Methods Mol Biol; 2014; 1102():481-99. PubMed ID: 24258994
[TBL] [Abstract][Full Text] [Related]
2. Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patients.
Sigalotti L; Fratta E; Bidoli E; Covre A; Parisi G; Colizzi F; Coral S; Massarut S; Kirkwood JM; Maio M
J Transl Med; 2011 May; 9():78. PubMed ID: 21615918
[TBL] [Abstract][Full Text] [Related]
3. AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.
Hoshimoto S; Kuo CT; Chong KK; Takeshima TL; Takei Y; Li MW; Huang SK; Sim MS; Morton DL; Hoon DS
J Invest Dermatol; 2012 Jun; 132(6):1689-97. PubMed ID: 22402438
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers in malignant cutaneous melanoma: gift horse or one-trick pony?
Martinez SR; Hoon DS
J Cell Biochem; 2005 Oct; 96(3):473-83. PubMed ID: 16088931
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic change in DNA structure may serve as marker for melanoma.
Oncology (Williston Park); 2012 Oct; 26(10):930. PubMed ID: 23176003
[No Abstract] [Full Text] [Related]
6. Molecular biology methods to improve diagnosis and prognosis of melanocytic tumors.
Wiesner T; Fried I; Cerroni L; Kutzner H
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():19-24. PubMed ID: 23721637
[No Abstract] [Full Text] [Related]
7. LINE-1 hypermethylation in peripheral blood of cutaneous melanoma patients is associated with metastasis.
De Araújo ÉS; Kashiwabara AY; Achatz MI; Moredo LF; De Sá BC; Duprat JP; Rosenberg C; Carraro DM; Krepischi AC
Melanoma Res; 2015 Apr; 25(2):173-7. PubMed ID: 25647737
[TBL] [Abstract][Full Text] [Related]
8. Pyrosequencing assay to measure LINE-1 methylation level in esophageal squamous cell carcinoma.
Iwagami S; Baba Y; Watanabe M; Shigaki H; Miyake K; Ida S; Nagai Y; Ishimoto T; Iwatsuki M; Sakamoto Y; Miyamoto Y; Baba H
Ann Surg Oncol; 2012 Aug; 19(8):2726-32. PubMed ID: 22187122
[TBL] [Abstract][Full Text] [Related]
9. Methylation of PTEN as a prognostic factor in malignant melanoma of the skin.
Lahtz C; Stranzenbach R; Fiedler E; Helmbold P; Dammann RH
J Invest Dermatol; 2010 Feb; 130(2):620-2. PubMed ID: 19798057
[No Abstract] [Full Text] [Related]
10. Mutation analysis in malignant melanoma.
Gaiser MR; Stadler R; Schirmacher P; Dietel M; Enk A
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():2-10. PubMed ID: 23721634
[No Abstract] [Full Text] [Related]
11. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
Saito K; Kawakami K; Matsumoto I; Oda M; Watanabe G; Minamoto T
Clin Cancer Res; 2010 Apr; 16(8):2418-26. PubMed ID: 20371677
[TBL] [Abstract][Full Text] [Related]
12. Long interspersed nucleotide element-1 hypomethylation in canine malignant mucosal melanoma.
Ishizaki T; Yamazaki J; Meagawa S; Yokoyama N; Aoshima K; Takiguchi M; Kimura T
Vet Comp Oncol; 2020 Dec; 18(4):854-860. PubMed ID: 32187810
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.
Moreau S; Saiag P; Aegerter P; Bosset D; Longvert C; Hélias-Rodzewicz Z; Marin C; Peschaud F; Chagnon S; Zimmermann U; Clerici T; Emile JF
Ann Surg Oncol; 2012 Dec; 19(13):4314-21. PubMed ID: 22772867
[TBL] [Abstract][Full Text] [Related]
14. Molecular markers in melanoma.
Kashani-Sabet M
Br J Dermatol; 2014 Jan; 170(1):31-5. PubMed ID: 23815339
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic classification of difficult melanocytic tumors.
Metzler G; Eigentler TK; Held L; Kind P; Hantschke M; Garbe C; Bauer J
J Dtsch Dermatol Ges; 2013 May; 11 Suppl 4():11-8. PubMed ID: 23721635
[No Abstract] [Full Text] [Related]
16. Update of diagnostic and prognostic markers in cutaneous malignant melanoma.
Reed JA; Albino AP
Clin Lab Med; 2000 Dec; 20(4):817-38. PubMed ID: 11221516
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.
Winnepenninckx V; van den Oord JJ
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas.
Cesinaro AM; Sartori G; Migaldi M; Schirosi L; Pellacani G; Collina G; Maiorana A
Pathology; 2012 Jun; 44(4):313-7. PubMed ID: 22544212
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic biomarkers in skin cancer.
Greenberg ES; Chong KK; Huynh KT; Tanaka R; Hoon DS
Cancer Lett; 2014 Jan; 342(2):170-7. PubMed ID: 22289720
[TBL] [Abstract][Full Text] [Related]
20. TSLC1 gene silencing in cutaneous melanoma.
You Y; Ma L; You M; Li X; Wang S; Li H; Wu D; Yang H; Li ZY
Melanoma Res; 2010 Jun; 20(3):179-83. PubMed ID: 20375924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
